40 results on '"C. Heery"'
Search Results
2. Area-Independent Effects of Water-Retaining Features on Intertidal Biodiversity on Eco-Engineered Seawalls in the Tropics
- Author
-
Lynette H. L. Loke, Eliza C. Heery, Samantha Lai, Tjeerd J. Bouma, and Peter A. Todd
- Subjects
habitat complexity ,ecological engineering ,urban marine ecology ,species-area relationship ,species-abundance relationship ,Science ,General. Including nature conservation, geographical distribution ,QH1-199.5 - Abstract
Over the last decade there has been a global effort to eco-engineer urban artificial shorelines with the aim of increasing their biodiversity and extending their conservation value. One of the most common and viable eco-engineering approaches on seawalls is to use enhancement features that increase habitat structural complexity, including concrete tiles molded with complex designs and precast “flowerpots” that create artificial rock pools. Increases in species diversity in pits and pools due to microhabitat conditions (water retention, shade, protection from waves, and/or biotic refugia) are often reported, but these results can be confounded by differences in the surface area sampled. In this study, we fabricated three tile types (n = 10): covered tile (grooved tile with a cover to retain water), uncovered tile (same grooved tile but without a cover) and granite control. We tested the effects of these tile types on species richness (S), total individual abundance (N), and community composition. All tiles were installed at 0.5 m above chart datum along seawalls surrounding two island sites (Pulau Hantu and Kusu Island) south of Singapore mainland. The colonizing assemblages were sampled after 8 months. Consistent with previous studies, mean S was significantly greater on covered tiles compared to the uncovered and granite tiles. While it is implied in much of the eco-engineering literature that this pattern results from greater niche availability allotted by microhabitat conditions, we further investigated whether there was an underlying species-individual relationship to determine whether increases in S could have simply resulted from covered tiles supporting greater N (i.e., increasing the probability of detecting more species despite a constant area). The species-individual relationship was positive, suggesting that multiple mechanisms are at play, and that biodiversity enhancements may in some instances operate simply by increasing the abundance of individuals, even when microhabitat availability is unchanged. This finding underscores the importance of testing mechanisms in eco-engineering studies and highlights ongoing mechanistic uncertainties that should be addressed to inform the design of more biodiverse seawalls and urban marine environments.
- Published
- 2019
- Full Text
- View/download PDF
3. Ecological engineering across organismal scales: trophic-mediated positive effects of microhabitat enhancement on fishes
- Author
-
Lynette H.L. Loke, Aaron Teo, Eliza C. Heery, Peter A. Todd, Andrew G. Bauman, and Daisuke Taira
- Subjects
0106 biological sciences ,Ecology ,010604 marine biology & hydrobiology ,Aquatic Science ,Biology ,Ecological engineering ,010603 evolutionary biology ,01 natural sciences ,Ecology, Evolution, Behavior and Systematics ,Trophic level - Abstract
Retrofitting microhabitat features is a common ecological engineering technique for enhancing biodiversity and abundance of small, epilithic organisms on artificial shorelines by providing refuge spaces and/or ameliorating abiotic conditions. These features are typically too small to be utilised as refugia by larger, highly motile consumers such as fish, but they may affect these organisms through other mechanisms. This study sought to determine whether microhabitat enhancement units alter the fish abundance, richness and assemblage composition on tropical seawalls and explores possible underlying trophic mechanisms. We created 12 experimental plots consisting of 6 enhanced plots, each with 20 microhabitat enhancement tiles, and 6 control plots without tiles on intertidal seawalls at Pulau Hantu, an offshore island south of mainland Singapore. Benthic cover and fish assemblage were surveyed within each plot using photoquadrats and underwater video cameras, respectively, from April 2018 to February 2019. We found greater abundance and species richness and distinct assemblages of fish in the enhanced plots compared to the control plots. These differences were driven largely by an increase in both abundance and richness of fish species with epibenthic-feeding strategies and were significantly associated with higher biotic cover in the enhanced plots, especially epilithic algal matrix (EAM). Our results indicate that, in addition to facilitating epilithic organisms, microhabitat enhancement can provide food resources for epibenthic-feeding fishes, increase fish biodiversity, and alter fish assemblages in tropical urbanised shorelines.
- Published
- 2020
4. Little evidence that lowering the pH of concrete supports greater biodiversity on tropical and temperate seawalls
- Author
-
Clark, Tmf Chai, J Ducker, Eliza C. Heery, WR Birch, Ar Hsiung, Lhl Loke, YS Pek, Louise B. Firth, Peter A. Todd, WT Tan, RS Hartanto, and Acf Ang
- Subjects
0106 biological sciences ,Ecology ,Agroforestry ,010604 marine biology & hydrobiology ,Temperate climate ,Biodiversity ,Environmental science ,Aquatic Science ,Ecological engineering ,010603 evolutionary biology ,01 natural sciences ,Ecology, Evolution, Behavior and Systematics - Abstract
Concrete is one of the most commonly used materials in the construction of coastal and marine infrastructure despite the well known environmental impacts which include a high carbon footprint and high alkalinity (~pH 13). There is an ongoing discussion regarding the potential positive effects of lowered concrete pH on benthic biodiversity, but this has not been investigated rigorously. Here, we designed a manipulative field experiment to test whether carbonated (lowered pH) concrete substrates support greater species richness and abundance, and/or alter community composition, in both temperate and tropical intertidal habitats. We constructed 192 experimental concrete tiles, half of which were carbonated to a lower surface pH of 7-8 (vs. control pH of >9), and affixed them to seawalls in the United Kingdom and Singapore. There were 2 sites per country, and 6 replicate tiles of each treatment were collected at 4 time points over a year. Overall, we found no significant effect of lowered pH on the abundance, richness, or community assemblage in both countries. Separate site- and month-specific generalised linear models (GLMs) showed only sporadic effects: i.e. lowered pH tiles had a small positive effect on early benthic colonisation in the tropics but this was later succeeded by similar species assemblages regardless of treatment. Thus, while it is worth considering the modification of concrete from an environmental/emissions standpoint, lowered pH may not be a suitable technique for enhancing biodiversity in the marine built environment.
- Published
- 2020
5. Current and projected global extent of marine built structures
- Author
-
Emma L. Johnston, Emma V. Sheehan, Melanie J. Bishop, Elisabeth M. A. Strain, Eliza C. Heery, Katherine A. Dafforn, Ross A. Coleman, Laura Airoldi, Ana B. Bugnot, Rebecca L. Morris, Mariana Mayer-Pinto, Lynette H.L. Loke, and Lincoln P. Critchley
- Subjects
Seascape ,Global and Planetary Change ,Ecology ,Renewable Energy, Sustainability and the Environment ,business.industry ,Geography, Planning and Development ,Environmental resource management ,Urban sprawl ,Exclusive economic zone ,Management, Monitoring, Policy and Law ,Urban Studies ,Environmental studies ,Urbanization ,Seascapes ,Environmental science ,business ,Baseline (configuration management) ,Spatial planning ,Nature and Landscape Conservation ,Food Science - Abstract
The sprawl of marine construction is one of the most extreme human modifications to global seascapes. Nevertheless, its global extent remains largely unquantified compared to that on land. We synthesized disparate information from a diversity of sources to provide a global assessment of the extent of existing and projected marine construction and its effects on the seascape. Here we estimated that the physical footprint of built structures was at least 32,000 km2 worldwide as of 2018, and is expected to cover 39,400 km2 by 2028. The area of seascape modified around structures was 1.0–3.4 × 106 km2 in 2018 and was projected to increase by 50–70% for power and aquaculture infrastructure, cables and tunnels by 2028. In 2018, marine construction affected 1.5% (0.7–2.4%) of global Exclusive Economic Zones, comparable to the global extent of urban land estimated at 0.02–1.7%. This study provides a critical baseline for tracking future marine human development.
- Published
- 2020
6. 620O CART-ddBCMA for multiple myeloma: Interim results from phase I study
- Author
-
M. Frigault, J. Rosenblatt, N. Raje, D. Cook, M. Gaballa, E. Emmanuel-Alejandro, C. Cornwell, K. Banerjee, A. Rotte, C. Heery, D. Avigan, A. Jakubowiak, and M. Bishop
- Subjects
Oncology ,Hematology - Published
- 2022
7. Last species standing: loss of Pocilloporidae corals associated with coastal urbanization in a tropical city state
- Author
-
Peter A. Todd, Danwei Huang, Sebastian Schmidt-Roach, Rosa Celia Poquita-Du, Karenne Tun, Zheng Bin Randolph Quek, Loke Ming Chou, Eliza C. Heery, and Sudhanshi Sanjeev Jain
- Subjects
0106 biological sciences ,geography ,geography.geographical_feature_category ,food.ingredient ,biology ,Ecology ,010604 marine biology & hydrobiology ,Coral ,fungi ,Biodiversity ,Pocilloporidae ,Coral reef ,Aquatic Science ,Oceanography ,biology.organism_classification ,010603 evolutionary biology ,01 natural sciences ,food ,Habitat destruction ,Pocillopora ,Seriatopora ,Reef ,geographic locations ,Ecology, Evolution, Behavior and Systematics - Abstract
Coral reefs worldwide are facing multiple severe stressors leading to ecosystem degradation, but local extinctions of species are not well documented. Here, we track the diversity of Pocilloporidae Gray, 1840 coral species—many of which are known to be sensitive to environmental disturbances—on Singapore reefs through time, integrating information from taxonomically verified museum specimens, careful examination of the literature, and DNA sequences. We found that more Pocilloporidae species were detected in the past than at present. A total of five species were historically recorded under Pocillopora Lamarck, 1816; Seriatopora Lamarck, 1816; and Stylophora Schweigger, 1820. Among the five species, only Pocillopora acuta Lamarck, 1816 appears to remain on Singapore reefs. The absence of Seriatopora for over half a century and the recent losses of Stylophora and the other species of Pocillopora are likely caused by habitat loss and other stressors associated with coastal urbanization, which have been further exacerbated by recent bleaching events.
- Published
- 2019
8. Material type weakly affects algal colonisation but not macrofaunal community in an artificial intertidal habitat
- Author
-
Rania S. Hartanto, Lynette H.L. Loke, Eliza C. Heery, Amanda R. Hsiung, Marcus W.X. Goh, Y. Shona Pek, William R. Birch, and Peter A. Todd
- Subjects
Environmental Engineering ,Management, Monitoring, Policy and Law ,Nature and Landscape Conservation - Published
- 2022
9. Not all artificial structures are created equal: Pilings linked to greater ecological and environmental change in sediment communities than seawalls
- Author
-
James A. Smith, Katherine A. Dafforn, Mariana Mayer-Pinto, Eliza C. Heery, and Shinjiro Ushiama
- Subjects
0106 biological sciences ,Conservation of Natural Resources ,Geologic Sediments ,Manufactured Materials ,Environmental change ,Population Dynamics ,Aquatic Science ,Bacterial Physiological Phenomena ,Oceanography ,010603 evolutionary biology ,01 natural sciences ,Rocky shore ,Animals ,Marine ecosystem ,Ecosystem ,Isotope analysis ,Trophic level ,Ecology ,010604 marine biology & hydrobiology ,Detritivore ,Sediment ,Biodiversity ,General Medicine ,Invertebrates ,Pollution ,Habitat ,Environmental science - Abstract
Artificial structures are agents of change in marine ecosystems. They add novel habitat for hard-substrate organisms and modify the surrounding environment. Most research to date has focused on the communities living directly on artificial structures, and more research is needed on the potential impacts these structures have on nearby communities and the surrounding environment. We compared the sedimentary habitat surrounding two types of artificial structures (pilings and seawalls) to sediments adjacent to rocky reefs using a combination of traditional sediment analyses, stable isotope analysis, and environmental DNA. Artificial and natural shore sediments were best differentiated by sediment variables strongly associated with flow speed. Pilings sediments had significantly finer grain size, higher organic content, and generally lower C:N ratios than sediments adjacent to the other habitat types, suggesting flow is reduced by pilings. Sedimentary assemblages near pilings were also consistent with those predicted under low-flow conditions, with elevated bacterial colonization and increased relative abundances of small deposit feeders compared with other habitat types. Additionally, lumbrinerid polychaetes in pilings sediments had reduced δ15N values, suggesting different detrital resources and fewer trophic linkages compared with lumbrinerids in other habitats. Woody detritus was greater adjacent to seawalls than to natural rocky shores or pilings. Our findings suggest that artificial structures have the potential to influence adjacent soft sediments through changes to sediment properties that affect infaunal and microbial communities, as well as trophic linkages for some consumers. We hypothesize that this is due to a combination of altered flow, differing detrital subsidies, and differing adjacent land-use among habitat types. Managers should consider the potential for changed sediment properties and ecology when deciding where to build different types of artificial structures. Further manipulative experiments are needed to understand mechanisms of change and help manage the impacts of artificial structures on the seafloor.
- Published
- 2018
10. The role of scientific expertise in local adaptation to projected sea level rise
- Author
-
Eliza C. Heery, Christine C. Stawitz, Adam L. Hayes, Anna K. McLaskey, and Elizabeth A. Maroon
- Subjects
education.field_of_study ,Government ,010504 meteorology & atmospheric sciences ,Process (engineering) ,business.industry ,Geography, Planning and Development ,Population ,0211 other engineering and technologies ,021107 urban & regional planning ,Context (language use) ,02 engineering and technology ,Plan (drawing) ,Management, Monitoring, Policy and Law ,Public relations ,01 natural sciences ,Politics ,Exchange of information ,Political science ,Adaptation (computer science) ,education ,business ,0105 earth and related environmental sciences - Abstract
Adaptation to sea level rise (SLR) is primarily taking place at the local level, with varied governments grappling with the diverse ways that SLR will affect cities. Interpreting SLR in the context of local planning requires integrating knowledge across many disciplines, and expert knowledge can help planners understand the potential ramifications of decisions. Little research has focused on the role that experts play in local adaptation planning. Understanding how and when local governments undertake adaptation planning, and how scientists and scientific information can be effectively incorporated into the planning process, is vital to guide scientists who wish to engage in the planning process. This study aimed to establish how experts are currently involved in SLR planning, identify any gaps between planners’ needs and expert involvement, and determine the characteristics of experts that are perceived as highly valuable to the planning process. We surveyed individuals involved with planning in a broad range of US coastal communities about SLR planning and the role that experts have played in the process. We found that SLR planning is widespread in cities across geographic regions, population sizes, and population characteristics and has increased rapidly since 2012. Contrary to our expectation, whether a SLR plan existed for each city was not related to the percentage of the population living on vulnerable lands or the property value of those lands. Almost all cities that have engaged in SLR planning involved experts in that process. Planners identify atmospheric scientists, oceanographers, economists and political scientists, and geologists as currently underutilized according to planners’ needs. Members of these expert disciplines, when involved in planning, were also unlikely to be affiliated with the local planning government, but rather came from other governmental and academic institutions. Highly effective experts were identified as making scientific research more accessible and bringing relevant research to the attention of planners. Results from our dataset suggest that planners perceive local SLR planning could benefit from increased involvement of experts, particularly atmospheric scientists, oceanographers, economists and political scientists, and geologists. Since experts in these disciplines were often not affiliated with local governments, increasing the exchange of information between local governments and academic and other (non-local) government organizations could help draw valued experts into the planning process.
- Published
- 2018
11. Reduced macrofauna diversity and abundance in response to red macroalgal detritus
- Author
-
Eliza C. Heery
- Subjects
0106 biological sciences ,Ecology ,010604 marine biology & hydrobiology ,fungi ,Detritus (geology) ,Aquatic Science ,Biology ,Plant litter ,biology.organism_classification ,010603 evolutionary biology ,01 natural sciences ,Wrack ,Macrophyte ,Seagrass ,Algae ,Benthic zone ,Ecosystem ,14. Life underwater ,Ecology, Evolution, Behavior and Systematics - Abstract
Macrophyte detritus from exogenous sources can play an important role in structuring benthic communities. Macrofaunal responses to seagrass wrack, mangrove leaf litter, and detritus from brown and green macroalgae have previously been examined through enrichment experiments. Yet effects from red macroalgal detritus, which is a major component of algal drift in many regions, are not well understood. In this study, enrichment experiments were performed on a shallow subtidal sandflat in Puget Sound, Washington, USA with detritus from three species of red macroalgae to assess: (1) whether macrofaunal assemblages were affected by two different “dosages” of red macroalgal enrichment (100 ml vs 500 ml per 0.079 m3 of sediment); (2) whether macrofaunal response differed between one-time and repeated (weekly) additions of red macroalgae; and (3) whether responses to red macroalgal enrichment changed over time. There appeared to be little or no effect on macrofauna from one-time enrichment regardless of the amount/dosage of algae added. However, weekly additions of red macroalgae led to negative responses across macrofaunal taxa. These responses occurred rapidly, within the first 3 weeks, and were largely unchanged after 7 weeks, intensifying for only 2 of the 10 most common taxa. No opportunistic responses to weekly additions were observed. Frequent influx of some types of red macroalgae may degrade the quality of sedimentary habitats by leaching chemically defensive compounds or through other mechanisms, which should be investigated in future studies. Although weekly enrichment treatments were informed by previous estimates of detrital delivery rates near hard-bottom habitats in the same locality, further research is needed to assess detrital influx frequency and community response in other regions where red macroalgal detritus is common, and to understand the broader implications of exogenous detritus from red macroalgae on benthic ecosystems.
- Published
- 2018
12. Urbanization-related distribution patterns and habitat-use by the marine mesopredator, giant Pacific octopus (Enteroctopus dofleini)
- Author
-
Amy Y. Olsen, Eliza C. Heery, Blake E. Feist, and Kenneth P. Sebens
- Subjects
0106 biological sciences ,Ecology ,biology ,010604 marine biology & hydrobiology ,15. Life on land ,Enteroctopus dofleini ,biology.organism_classification ,010603 evolutionary biology ,01 natural sciences ,Predation ,Urban Studies ,Mesopredator release hypothesis ,Urban ecology ,Geography ,Habitat ,Benthic zone ,Abundance (ecology) ,Urbanization ,14. Life underwater - Abstract
Urbanization is a process that heavily alters marine and terrestrial environments, though terrestrial urban ecosystems have been studied far more intensively. Terrestrial studies suggest that urbanization can facilitate mesopredators by enhancing food and shelter resources and reducing predation pressure from apex consumers. This in turn has considerable consequences for ecological communities. We evaluated spatial distribution patterns and habitat-use of the marine mesopredator, giant Pacific octopus (Enteroctopus dofleini), relative to terrestrial urbanization intensity in Puget Sound, Washington, USA. Using field surveys and citizen-contributed data for E. dofleini, we examined whether: (1) Distribution was related to urbanization, (2) Abundance was related to the extent of benthic anthropogenic debris, and (3) Diet differed as a function of urbanization and den cover. Our results suggest that urbanization impacts may differ with depth. Mixed-effects logistic regression model estimates for the probability of occurrence increased with urbanization in deep-water (> 24 m), and decreased with urbanization in shallow water (< 18 m). Accompanying field surveys indicated that E. dofleini abundance was correlated with the number of benthic anthropogenic debris items, and that E. dofleini diets were not affected by urbanization intensity or den cover. Though E. dofleini may be synanthropic within certain urban environments, the mechanisms driving this pattern likely differ from those affecting common urban mesopredators on land, with den provisioning from man-made structures being more important than altered food resources.
- Published
- 2018
13. Antagonistic effects of seawalls and urban sedimentation on epilithic algal matrix (EAM)-feeding fishes
- Author
-
Dillen Ng, Daisuke Taira, Peter A. Todd, and Eliza C. Heery
- Subjects
Geologic Sediments ,Coral reef fish ,Field experiment ,Aquatic Science ,Oceanography ,Urbanization ,Animals ,Humans ,Reef ,Ecosystem ,geography ,geography.geographical_feature_category ,Coral Reefs ,Ecology ,fungi ,Fishes ,Sediment ,Coral reef ,biochemical phenomena, metabolism, and nutrition ,Sedimentation ,Anthozoa ,Pollution ,Habitat ,Environmental science ,geographic locations - Abstract
Marine urbanisation often results in the proliferation of artificial coastal defences and heavy sedimentation, adversely impacting coral reef systems in tropical coastal cities. Knowledge of how motile organisms, such as reef fish, respond to novel human-made habitats and high sedimentation is limited. Here, we examine the role of sloping granite seawalls in supporting reef fishes that utilise the epilithic algal matrix (EAM) as a food resource. We surveyed fish assemblages and feeding activities on seawalls and reef flats, and conducted a field experiment to examine the effects of sediment on EAM feeding rates. Seawalls and reef flats supported distinct fish assemblage composition with significantly greater feeding activity on seawalls. However, reduced feeding activity on EAM with elevated sediment loads suggests that urban sedimentation may limit the utility of this novel feeding ground for nearshore communities. These findings illustrate the complexities and interactive effects of anthropogenic changes driven by coastal urbanisation.
- Published
- 2021
14. Identifying the consequences of ocean sprawl for sedimentary habitats
- Author
-
Mariana Mayer-Pinto, Melanie J. Bishop, Eliza C. Heery, Larissa A. Naylor, Valeriya Komyakova, Ana B. Bugnot, Ross A. Coleman, Rebecca L. Morris, Emma V. Sheehan, Lincoln P. Critchley, Katherine A. Dafforn, Elisabeth M. A. Strain, Lynette H.L. Loke, Laura Airoldi, Emma L. Johnston, Heery, Eliza C, Bishop, Melanie J., Critchley, Lincoln P., Bugnot, Ana B., Airoldi, Laura, Mayer-Pinto, Mariana, Sheehan, Emma V., Coleman, Ross A., Loke, Lynette H.L., Johnston, Emma L., Komyakova, Valeriya, Morris, Rebecca L., Strain, Elisabeth M.A., Naylor, Larissa A., and Dafforn, Katherine A.
- Subjects
0106 biological sciences ,Evolution ,Biodiversity ,Aquatic Science ,Biology ,010603 evolutionary biology ,01 natural sciences ,Offshore wind farm ,Coastal defense ,Behavior and Systematics ,Ecosystem ,14. Life underwater ,Artificial structure ,Ecological impact ,Marine sediment ,Urbanization ,Ecology ,Ecology, Evolution, Behavior and Systematics ,010604 marine biology & hydrobiology ,fungi ,Marine habitats ,Cumulative effects ,Urban sprawl ,15. Life on land ,Ecology, Evolution, Behavior and Systematic ,Habitat destruction ,Habitat ,13. Climate action ,Sedimentary rock - Abstract
Extensive development and construction in marine and coastal systems is driving a phenomenon known as “ocean sprawl”. Ocean sprawl removes or transforms marine habitats through the addition of artificial structures and some of the most significant impacts are occurring in sedimentary environments. Marine sediments have substantial social, ecological, and economic value, as they are rich in biodiversity, crucial to fisheries productivity, and major sites of nutrient transformation. Yet the impact of ocean sprawl on sedimentary environments has largely been ignored. Here we review current knowledge of the impacts to sedimentary ecosystems arising from artificial structures.\ud \ud Artificial structures alter the composition and abundance of a wide variety of sediment-dependent taxa, including microbes, invertebrates, and benthic-feeding fishes. The effects vary by structure design and configuration, as well as the physical, chemical, and biological characteristics of the environment in which structures are placed. The mechanisms driving effects from artificial structures include placement loss, habitat degradation, modification of sound and light conditions, hydrodynamic changes, organic enrichment and material fluxes, contamination, and altered biotic interactions. Most studies have inferred mechanism based on descriptive work, comparing biological and physical processes at various distances from structures. Further experimental studies are needed to identify the relative importance of multiple mechanisms and to demonstrate causal relationships. Additionally, past studies have focused on impacts at a relatively small scale, and independently of other development that is occurring. There is need to quantify large-scale and cumulative effects on sedimentary ecosystems as artificial structures proliferate. We highlight the importance for comprehensive monitoring using robust survey designs and outline research strategies needed to understand, value, and protect marine sedimentary ecosystems in the face of a rapidly changing environment.
- Published
- 2017
15. Towards an urban marine ecology : characterizing the drivers, patterns and processes of marine ecosystems in coastal cities
- Author
-
Lynette H.L. Loke, Christopher M. Swan, Peter A. Todd, Eliza C. Heery, Ruth H. Thurstan, D. Johan Kotze, Helsinki Institute of Sustainability Science (HELSUS), Helsinki Institute of Urban and Regional Studies (Urbaria), Urban Ecosystems, and Ecosystems and Environment Research Programme
- Subjects
0106 biological sciences ,CORAL-REEFS ,FISH FUNDULUS-HETEROCLITUS ,ecological engineering ,LOWER GENETIC DIVERSITY ,Climate change ,ARTIFICIAL STRUCTURES ,010501 environmental sciences ,01 natural sciences ,POLYCYCLIC AROMATIC-HYDROCARBONS ,11. Sustainability ,Marine ecosystem ,pollution pathways ,14. Life underwater ,NATURAL ROCKY SHORES ,ocean sprawl ,Ecology, Evolution, Behavior and Systematics ,Exploitation of natural resources ,1172 Environmental sciences ,0105 earth and related environmental sciences ,geography.geographical_feature_category ,Ecology ,010604 marine biology & hydrobiology ,INTERTIDAL ASSEMBLAGES ,resource exploitation ,Coral reef ,15. Life on land ,Ecological engineering ,HEDISTE-DIVERSICOLOR POLYCHAETA ,Geography ,climate change ,HEAVY-METAL POLLUTION ,13. Climate action ,SAN-FRANCISCO BAY - Abstract
Human population density within 100 km of the sea is approximately three times higher than the global average. People in this zone are concentrated in coastal cities that are hubs for transport and trade - which transform the marine environment. Here, we review the impacts of three interacting drivers of marine urbanization (resource exploitation, pollution pathways and ocean sprawl) and discuss key characteristics that are symptomatic of urban marine ecosystems. Current evidence suggests these systems comprise spatially heterogeneous mosaics with respect to artificial structures, pollutants and community composition, while also undergoing biotic homogenization over time. Urban marine ecosystem dynamics are often influenced by several commonly observed patterns and processes, including the loss of foundation species, changes in biodiversity and productivity, and the establishment of ruderal species, synanthropes and novel assemblages. We discuss potential urban acclimatization and adaptation among marine taxa, interactive effects of climate change and marine urbanization, and ecological engineering strategies for enhancing urban marine ecosystems. By assimilating research findings across disparate disciplines, we aim to build the groundwork for urban marine ecology - a nascent field; we also discuss research challenges and future directions for this new field as it advances and matures. Ultimately, all sides of coastal city design: architecture, urban planning and civil and municipal engineering, will need to prioritize the marine environment if negative effects of urbanization are to be minimized. In particular, planning strategies that account for the interactive effects of urban drivers and accommodate complex system dynamics could enhance the ecological and human functions of future urban marine ecosystems.
- Published
- 2019
16. The North-East Pacific
- Author
-
Kenneth P. Sebens and Eliza C. Heery
- Subjects
Oceanography ,Geography ,El Niño ,Benthic zone ,Upwelling ,North east ,Pacific decadal oscillation ,Kelp forest - Published
- 2019
17. Design Options, Implementation Issues and Evaluating Success of Ecologically Engineered Shorelines
- Author
-
Andrew Rella, Edward Lau, Laura Airoldi, Peter D. Steinberg, Lynette H.L. Loke, Louise B. Firth, Jeffery R. Cordell, Tom Heath, Richard C. Thompson, Michael Kokora, Peter A. Todd, Yunwei Dong, Ross A. Coleman, Eliza C. Heery, Shing Yip Lee, Melanie J. Bishop, Stephen J. Hawkins, Jason D. Toft, Kenneth M.Y. Leung, Karen A. Alexander, Jon K. Miller, Shimrit Perkol-Finkel, Rebecca L. Morris, Ichiro Takeuchi, and Elisabeth M. A. Strain
- Subjects
Extreme weather ,Flood myth ,Urban planning ,Population growth ,Climate change ,Ecological engineering ,Environmental planning ,Port (computer networking) ,Ecosystem services - Abstract
Human population growth and accelerating coastal development have been the drivers for unprecedented construction of artificial structures along shorelines globally. Construction has been recently amplified by societal responses to reduce flood and erosion risks from rising sea levels and more extreme storms resulting from climate change. Such structures, leading to highly modified shorelines, deliver societal benefits, but they also create significant socioeconomic and environmental challenges. The planning, design and deployment of these coastal structures should aim to provide multiple goals through the application of ecoengineering to shoreline development. Such developments should be designed and built with the overarching objective of reducing negative impacts on nature, using hard, soft and hybrid ecological engineering approaches. The design of ecologically sensitive shorelines should be context-dependent and combine engineering, environmental and socioeconomic considerations. The costs and benefits of ecoengineered shoreline design options should be considered across all three of these disciplinary domains when setting objectives, informing plans for their subsequent maintenance and management and ultimately monitoring and evaluating their success. To date, successful ecoengineered shoreline projects have engaged with multiple stakeholders (e.g. architects, engineers, ecologists, coastal/port managers and the general public) during their conception and construction, but few have evaluated engineering, ecological and socioeconomic outcomes in a comprehensive manner. Increasing global awareness of climate change impacts (increased frequency or magnitude of extreme weather events and sea level rise), coupled with future predictions for coastal development (due to population growth leading to urban development and renewal, land reclamation and establishment of renewable energy infrastructure in the sea) will increase the demand for adaptive techniques to protect coastlines. In this review, we present an overview of current ecoengineered shoreline design options, the drivers and constraints that influence implementation and factors to consider when evaluating the success of such ecologically engineered shorelines.
- Published
- 2019
18. Contributors
- Author
-
Olubukola Adebambo, Tundi Agardy, Andrew E. Allen, Andrew H. Altieri, Francisco Andrade, Michela Angiolillo, Stephanie Avery-Gomm, Jiayu Bai, Joel Baker, Luís Gabriel A. Barboza, Thayanne Lima Barros, John M. Baxter, Daniel T.I. Bayley, Luca G. Bellucci, Charles Birkeland, Alex Bond, Andy M. Booth, Stephanie Borrelle, Jessica Bradford, Paula Bueno, Gabrielle Canonico Hyde, Bing Chen, Jing Cheng, Andrés Cózar, Rory Crawford, Larry B. Crowder, Jordi Dachs, Rosa M. Darbra, Matej David, Jon C. Day, Monica C. Del Aguila Feijoo, Robert J. Diaz, Anni Djurhuus, Zhijun Dong, Stuart Johnston Edwards, Charles N. Ehler, Elias Elhaimer, Karen Filbee-Dexter, Ramón Filgueira, Merv Fingas, Greg Foster, Catarina Frazão Santos, João P.G.L. Frias, Daniel A. Friess, Barbara C.G. Gimenez, Silvia Giuliani, Stephan Gollasch, Thomas P. Good, Kelly D. Goodwin, Lúcia Guilhermino, Jeff Hatfield, Eliza C. Heery, Peter Hodum, Tahazzud Hossain, Liang Jing, Peter J. Kershaw, Kira Krumhansl, Dan Laffoley, Shing Yip Lee, Kenneth Lee, Julie A. Lively, Rainer Lohmann, Lynette H.L. Loke, Heather L. Major, Mark Mallory, Julie Masura, Ethan J. Matchinski, Karen D. McCoy, John P. McCrow, Flemming Merkel, Andrew O.M. Mogg, Courtney E. Morrison, Frank E. Muller-Karger, Michael K. Orbach, Simone Panigada, Daniel Pauly, Morten F. Pedersen, Marta Picciulin, Jurgenne H. Primavera, Jennifer F. Provencher, Martí Puig, Nikolina Rako-Gospić, Michelle Reynolds, Fabian Ritter, David Rodríguez-Rodríguez, Alex D. Rogers, Jessica Romo, Nameeta Sharma, Richard B. Sherley, Dena Spatz, Laura Steeves, Nora F.Y. Tam, Stephanie Taylor, Peter A. Todd, Hanneke Van Lavieren, Luís R. Vieira, Stephen Votier, Jill Wakefield, Tony R. Walker, Yafen Wang, Jenny Weitzman, Lauren Wenzel, Thomas Wernberg, Xudong Ye, Lisa Zeigler Allen, Dirk Zeller, Baiyu Zhang, Katherine Zischka, and Sanam Zomorodi
- Published
- 2019
19. Human-engineered hydrodynamic regimes as a driver of cryptic microinvertebrate assemblages on urban artificial shorelines
- Author
-
C.K. Chim, Daisuke Taira, Lynette H.L. Loke, Dillen Ng, Tiffany M.F. Chai, Rachel K.E. Oh, Amanda R. Hsiung, Eliza C. Heery, Peter A. Todd, Hannah H.J. Yeo, and Rania S. Hartanto
- Subjects
Population Density ,Abiotic component ,Singapore ,Environmental Engineering ,010504 meteorology & atmospheric sciences ,Ecology ,Intertidal zone ,Biota ,010501 environmental sciences ,01 natural sciences ,Pollution ,Transplantation ,Benthic zone ,Abundance (ecology) ,Hydrodynamics ,Animals ,Humans ,Environmental Chemistry ,Environmental science ,Marine ecosystem ,Coastal engineering ,Waste Management and Disposal ,Ecosystem ,0105 earth and related environmental sciences - Abstract
Urban shorelines undergo substantial hydrodynamic changes as a result of coastal engineering and shoreline armouring that can alter sedimentation, turbidity, and other factors. These changes often coincide with major shifts in the composition and distribution of marine biota, however, rarely are hydrodynamic-mediated factors confirmed experimentally as the mechanism underpinning these shifts. This study first characterized hydrodynamic-related distribution patterns among epilithic and epiphytic microinvertebrates on urban seawalls in Singapore. We found reduced microinvertebrate abundances and distinct microinvertebrate community structure within benthic turf algae in areas where coastal defences had reduced wave energy and increased sediment deposition, among other hydrodynamic-related abiotic changes. Low-exposure areas also had reduced densities of macroinvertebrate grazers and less dense turf algae (lower mass per cm2) than adjacent high-exposure areas. Using harpacticoid copepods as a model taxon, we performed a reciprocal transplant experiment to discern between the effects of exposure-related conditions and grazing. Results from the experiment indicate that conditions associated with restricted wave energy from shoreline engineering limit harpacticoid population densities, as transplantation to low-exposure areas led to rapid reductions in abundance. At the same time, we found no effect from grazer exclusion cages, suggesting harpacticoids are minimally impacted by exposure-related gradients in gastropod macrograzer densities over short time scales. Given the key role of intertidal microinvertebrates, particularly harpacticoids, in nearshore food webs, we postulate that human-engineered hydrodynamic regimes are an important factor shaping marine ecosystem functioning in urban areas.
- Published
- 2020
20. Evaluating seaweed farming as an eco-engineering strategy for ‘blue’ shoreline infrastructure
- Author
-
Kay Yee Lian, Peter A. Todd, Lynette H.L. Loke, Hugh T. W. Tan, and Eliza C. Heery
- Subjects
Environmental Engineering ,Tidal range ,business.industry ,Environmental resource management ,04 agricultural and veterinary sciences ,010501 environmental sciences ,Management, Monitoring, Policy and Law ,Ecological engineering ,01 natural sciences ,Seaweed farming ,Seawall ,Work (electrical) ,Field trial ,Urbanization ,040103 agronomy & agriculture ,0401 agriculture, forestry, and fisheries ,Environmental science ,business ,Life-cycle assessment ,0105 earth and related environmental sciences ,Nature and Landscape Conservation - Abstract
Green spaces and agronomy have long been used in terrestrial urban environments to help mitigate the negative effects of urbanization on social-ecological systems. However, they represent an unexplored frontier in marine urban environments, which are also central to human–environment interactions in coastal cities. We evaluated the feasibility and potential environmental impacts of integrating small-scale seaweed farming into urban seawalls. We developed and tested the efficacy of a prototype “planter” unit for cultivating the red, agar-producing seaweed, Hydropuntia edulis, above its typical tidal range on urban seawalls in Singapore. Field trial results suggest that H. edulis can be successfully grown in the mid- and upper-intertidal zones on seawalls by using planters with water-retaining features. However, based on results from life cycle assessment (LCA) and integrated biological models of seaweed production, we found that the choice of materials for constructing planters and their positioning on the seawall were critical in determining net environmental impacts. Farmed seaweeds had an impressive capacity for carbon, nutrient, and metal uptake according to model estimates, but these benefits were outweighed by emissions from energy- and contaminant-intensive materials that are commonly used in seawall “eco-engineering.” At low tidal heights, farmed seaweeds were also more readily dislodged, potentially leading to greater flux of detrital biomass to adjacent systems. This work highlights both the potential of seaweed farming for enhancing the multifunctionality of urban waterfronts, and the importance of objectively weighing overall environmental consequences of such approaches before advancing them as eco-engineering solutions.
- Published
- 2020
21. Distribution of sea cucumbers, Holothuria atra, on reefs in the upper Gulf of Thailand and the effect of their population densities on sediment microalgal productivity
- Author
-
Chalothon Raksasab, Eliza C. Heery, Voranop Viyakarn, and Suchana Chavanich
- Subjects
0106 biological sciences ,geography ,Biomass (ecology) ,education.field_of_study ,geography.geographical_feature_category ,010504 meteorology & atmospheric sciences ,biology ,Overfishing ,organic chemicals ,010604 marine biology & hydrobiology ,Population ,Aquatic Science ,Oceanography ,biology.organism_classification ,01 natural sciences ,Population density ,biological factors ,Fishery ,Holothuria atra ,Sea cucumber ,Productivity (ecology) ,education ,neoplasms ,Reef ,0105 earth and related environmental sciences - Abstract
Populations of sea cucumbers in Thailand have been declining because of overfishing in recent years; however, little is known about the possible long-term effects of this decline on the sea cucumber population and reef communities. The purpose of this study was to examine the distribution patterns and habitat compositions of Holothuria atra in the upper Gulf of Thailand. In addition, field and laboratory experiments were conducted to investigate the impact of sea cucumber density and feeding activity on the sedimentary microalgal community. The results showed that there was a correlation between the density of H. atra and substrate composition. The density of H. atra increased as the percentage of sand cover in the habitats increased. High concentrations of chlorophyll–a were detected in gut contents. In addition, results from field and laboratory experiments showed that when H. atra was absent, a high concentration of chlorophyll-a in the reef sediment was recorded. The higher the number of H. atra, the greater the capability to reduce the microalgal biomass in the sediment. Thus, H. atra plays an important role in recycling nutrient in reefs in the Gulf of Thailand, and consequently, a decline in the sea cucumber population may alter the reef community.
- Published
- 2020
22. Urban coral reefs: Degradation and resilience of hard coral assemblages in coastal cities of East and Southeast Asia
- Author
-
Loke Ming Chou, Thamasak Yeemin, Makamas Sutthacheep, Muhammad Ali Syed Hussein, Eliza C. Heery, Daniel A. Friess, Jamaluddin Jompa, James Davis Reimer, Daisuke Taira, Lynette H.L. Loke, Zarinah Waheed, Nadia Alsagoff, Girley S. Gumanao, Ofri Johan, Arthur R. Bos, Suharsono, Danwei Huang, Andreas Kunzmann, Put O. Ang, Andrew G. Bauman, David J. W. Lane, Peter A. Todd, Si Tuan Vo, Bert W. Hoeksema, Poonam Saksena-Taylor, and Nicola K. Browne
- Subjects
0106 biological sciences ,Coral ,Aquatic Science ,Oceanography ,010603 evolutionary biology ,01 natural sciences ,Japan ,Urbanization ,Dominance (ecology) ,Animals ,Cities ,Reef ,Asia, Southeastern ,Ecosystem ,Shore ,geography ,Singapore ,geography.geographical_feature_category ,Conservation of Water Resources ,Ecology ,Coral Reefs ,010604 marine biology & hydrobiology ,Water Pollution ,Coral reef ,Ecological engineering ,Anthozoa ,Pollution ,Urban ecology ,Indonesia ,Reef compression ,Reef restoration ,Hong Kong - Abstract
Given predicted increases in urbanization in tropical and subtropical regions, understanding the processes shaping urban coral reefs may be essential for anticipating future conservation challenges. We used a case study approach to identify unifying patterns of urban coral reefs and clarify the effects of urbanization on hard coral assemblages. Data were compiled from 11 cities throughout East and Southeast Asia, with particular focus on Singapore, Jakarta, Hong Kong, and Naha (Okinawa). Our review highlights several key characteristics of urban coral reefs, including “reef compression” (a decline in bathymetric range with increasing turbidity and decreasing water clarity over time and relative to shore), dominance by domed coral growth forms and low reef complexity, variable city-specific inshore-offshore gradients, early declines in coral cover with recent fluctuating periods of acute impacts and rapid recovery, and colonization of urban infrastructure by hard corals. We present hypotheses for urban reef community dynamics and discuss potential of ecological engineering for corals in urban areas.
- Published
- 2018
23. Best practices for the management of local-regional recurrent chordoma: a position paper by the chordoma global consensus group
- Author
-
Vittoria Colia, Bernd Kasper, R. Imai, Michael Baumann, Stéphanie Bolle, R. Capanna, Riccardo Casadei, Paolo G. Casali, Claire Alapetite, P. A. Gardner, C. L. A. Vleggeert-Lankamp, C. Heery, Elena Tamborini, Anant Desai, Stefano Radaelli, Alessandro Gronchi, Nadia Hindi, Akira Kawai, Daniel Vanel, C. Sen, Francesco Doglietto, Nicolas Penel, Ziya L. Gokaslan, S. Froelich, Katherine Anne Thornton, Carlo Morosi, Hans Gelderblom, Francis J. Hornicek, O. J. Norum, M. Uhl, Palma Dileo, Sandip Pravin Patel, Piero Fossati, J. Martin Broto, Peter Hohenberger, Rick L. Haas, Andreas Leithner, Toru Akiyama, F. Ricchini, Robin L. Jones, Valter Torri, Josh Sommer, Peter Pal Varga, Y. Yamada, Per-Ulf Tunn, J.-Y. Blay, Augusto Caraceni, Piotr Rutkowski, Jürgen Debus, Lee Jeys, Adrienne M. Flanagan, Diego Mazzatenta, I. Logowska, Marco Krengli, Damien C. Weber, Thomas F. DeLaney, Susanne Scheipl, P. Picci, Beate Timmermann, Piero Nicolai, S. Pilotti, P. Bruzzi, Silvia Stacchiotti, Stefano Boriani, S. Dijkstra, Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan], European Institute of Oncology [Milan] (ESMO), Saitama University, Institut Curie [Paris], University of Dresden Medical School, Centre Léon Bérard [Lyon], Institut Gustave Roussy (IGR), University of Pisa - Università di Pisa, University Medical Center Heidelberg, Massachusetts General Hospital [Boston], Queen Elizabeth Hospital, University College London Hospitals (UCLH), Universiteit Leiden [Leiden], University of Brescia, Cancer Research UK London Research Institute, Hôpital Lariboisière, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), University of Pittsburgh School of Medicine, Pennsylvania Commonwealth System of Higher Education (PCSHE), Providence University, Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek Hospital, National Cancer Institute [Bethesda] (NCI-NIH), National Institutes of Health [Bethesda] (NIH), Hospital Universitario Virgen del Rocío [Sevilla], University of Heidelberg, Medical Faculty, Harvard Medical School [Boston] (HMS), Chiba University Hospital, Queens Elizabeth Hospital [Birmingham], Royal Marsden NHS Foundation Trust, National Cancer Center Research Institute [Tokyo], Università del Piemonte Orientale - Dipartimento DISIT Italy, Medical University Graz, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (MCMCC), MD Anderson Cancer Center [Houston], The University of Texas Health Science Center at Houston (UTHealth), Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), University Hospital Graz, New York University Langone Medical Center (NYU Langone Medical Center), NYU System (NYU), University of Duisbourg-Essen, Helios Klinikum [Erfurt], Memorial Sloane Kettering Cancer Center [New York], SwissFEL, Paul Scherrer Institut, Leiden University Medical Center (LUMC), Universiteit Leiden, CHU Lille, Université de Lille, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, European Institute of Oncology [Milan] [ESMO], Institut Gustave Roussy [IGR], University College London Hospitals [UCLH], Netherlands Cancer Institute [NKI], National Cancer Institute [Bethesda] [NCI-NIH], Harvard Medical School [Boston] [HMS], Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology [MCMCC], Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS], New York University Langone Medical Center [NYU Langone Medical Center], Leiden University Medical Center [LUMC], Stacchiotti, S., Gronchi, A., Fossati, P., Akiyama, T., Alapetite, C., Baumann, M., Blay, J. Y., Bolle, S., Boriani, S., Bruzzi, P., Capanna, R., Caraceni, A., Casadei, R., Colia, V., Debus, J., Delaney, T., Desai, A., Dileo, P., Dijkstra, S., Doglietto, F., Flanagan, A., Froelich, S., Gardner, P. A., Gelderblom, H., Gokaslan, Z. L., Haas, R., Heery, C., Hindi, N., Hohenberger, P., Hornicek, F., Imai, R., Jeys, L., Jones, R. L., Kasper, B., Kawai, A., Krengli, M., Leithner, A., Logowska, I., Martin Broto, J., Mazzatenta, D., Morosi, C., Nicolai, P., Norum, O. J., Patel, S., Penel, N., Picci, P., Pilotti, S., Radaelli, S., Ricchini, F., Rutkowski, P., Scheipl, S., Sen, C., Tamborini, E., Thornton, K. A., B., Timmermann, Torri, V., Tunn, P. U., Uhl, M., Yamada, Y., Weber, D. C., Vanel, D., Varga, P. P., Vleggeert-Lankamp, C. L. A., Casali, P. G., and Sommer, J.
- Subjects
sarcoma ,[SDV]Life Sciences [q-bio] ,Medizin ,chemotherapy ,Patient advocacy ,surgery ,0302 clinical medicine ,Neoplasm Recurrence ,Medicine ,chordoma ,relapse ,radiotherapy ,Relapse ,Sarcoma ,Hematology ,3. Good health ,Oncology ,030220 oncology & carcinogenesis ,Practice Guidelines as Topic ,chordoma, consensus, recurrence ,Sacral Chordoma ,musculoskeletal diseases ,medicine.medical_specialty ,recurrence ,Best practice ,MEDLINE ,Reviews ,610 Medicine & health ,03 medical and health sciences ,Chordoma ,Humans ,Chemotherapy ,Medical physics ,Radiotherapy ,business.industry ,medicine.disease ,Cervical spine ,consensus ,Family medicine ,Position paper ,Surgery ,Neoplasm Recurrence, Local ,business ,030217 neurology & neurosurgery - Abstract
Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and suboptimal outcomes for many patients. To address this shortcoming, the European Society of Medical Oncology (ESMO) and the Chordoma Foundation, the global chordoma patient advocacy group, convened a multi-disciplinary group of chordoma specialists to define by consensus evidence-based best practices for the optimal approach to chordoma. In January 2015, the first recommendations of this group were published, covering the management of primary and metastatic chordomas. Additional evidence and further discussion were needed to develop recommendations about the management of local-regional failures. Thus, ESMO and CF convened a second consensus group meeting in November 2015 to address the treatment of locally relapsed chordoma. This meeting involved over 60 specialists from Europe, the United States and Japan with expertise in treatment of patients with chordoma. The consensus achieved during that meeting is the subject of the present publication and complements the recommendations of the first position paper.
- Published
- 2017
24. Co-occurrence of bycatch and target species in the groundfish demersal trawl fishery of the U.S. west coast; with special consideration of rebuilding stocks
- Author
-
Jason M. Cope and Eliza C. Heery
- Subjects
education.field_of_study ,Biomass (ecology) ,Ecology ,Population ,Fishing ,Fisheries ,Aquatic Science ,Biology ,Demersal zone ,Management ,Fishery ,Bycatch ,Rockfish ,Groundfish ,Fisheries management ,education - Abstract
Bycatch and resultant discard mortality are issues of global concern. The groundfish demersal trawl fishery on the west coast of the United States is a multispecies fishery with significant catch of target and nontarget species. These catches are of particular concern in regard to species that have previously been declared overfished and are currently rebuilding biomass back to target levels. To understand these interactions better, we used data from the West Coast Groundfish Observer Program in a series of cluster analyses to evaluate 3 questions: 1) Are there identifiable associations between species caught in the bottom trawl fishery; 2) Do species that are undergoing population rebuilding toward target biomass levels (“rebuilding species”) cluster with targeted species in a consistent way; 3) Are the relationships between rebuilding bycatch species and target species more resolved at particular spatial scales or are relationships spatially consistent across the whole data set? Two strong species clusters emerged—a deepwater slope cluster and a shelf cluster—neither of which included rebuilding species. The likelihood of encountering rebuilding rockfish species is relatively low. To evaluate whether weak clustering of rebuilding rockfish was attributable to their low rate of occurrence, we specified null models of species occurrence. Results indicated that the ability to predict occurrence of rebuilding rockfish when target species were caught was low. Cluster analyses performed at a variety of spatial scales indicated that the most reliable clustering of rebuilding species was at the spatial scale of individual fishing ports. This finding underscores the value of spatially resolved data for fishery management.
- Published
- 2014
25. Discarding and fishing mortality trends in the U.S. west coast groundfish demersal trawl fishery
- Author
-
Marlene A. Bellman and Eliza C. Heery
- Subjects
Bycatch ,Bottom fishing ,Fishery ,Oceanography ,Individual fishing quota ,Fishing ,Sustainable fishery ,Groundfish ,Fisheries management ,Aquatic Science ,Biology ,Demersal zone - Abstract
Quantifying discarded catch is needed to guide effective fishery management and recognize the unintended impacts of fishing; ultimately to promote a more sustainable fishery. To understand fishing mortality prior to the establishment of an IFQ management system, we provide estimates of discarded and total catch (sum of discard and landings) in the U.S. west coast groundfish demersal trawl fishery from 2002 to 2009. West Coast Groundfish Observer Program (WCGOP) data were expanded to fleet-level discard estimates using a ratio estimator. Total estimated discard in the fishery declined by 52% across the study period. On average, 29% of the annual groundfish catch was discarded at-sea. A high proportion of catch was discarded during 2002, but subsequently overall discard decreased even though fishing effort (landings and trawl tow hours) increased in the fishery from 2004 to 2009. The largest components of discard (by weight) were Pacific hake (Merluccius productus), arrowtooth flounder (Atheresthes stomias), skates (Rajidae sp.) and spiny dogfish (Squalus acanthias). In 2009 relative to 2002, the discarded fraction of catch for rebuilding species, which constrain the fishery, had increased by 39%. In contrast, the discarded fraction of catch for target species had decreased by 24%. In addition, much of the fishing effort shifted to deeper waters. Our results represent a baseline for future comparisons as the fishery shifted from trip limit management to an Individual Fishing Quota (IFQ) program in 2011.
- Published
- 2013
26. Systematic Errors in Length Frequency Data and their Effect on Age-Structured Stock Assessment Models and Management
- Author
-
Jim Berkson and Eliza C. Heery
- Subjects
Systematic error ,Stock assessment ,Sampling process ,Statistics ,Econometrics ,Length frequency ,Systematic sampling ,Aquatic Science ,Life history ,Age structured ,Ecology, Evolution, Behavior and Systematics ,Stock (geology) ,Mathematics - Abstract
Length frequency data are a central component of many statistical age-structured models, which are used widely to conduct fisheries stock assessments and produce estimates of stock status for management. However, these data can be biased due to systematic errors during the sampling process. This study examined how bias in length frequency data affected stock status estimates from an age-structured assessment model and subsequent prescribed management actions. A simulation approach was used to test the effect of two different scenarios of bias on assessment results. Populations were simulated based on life history parameters for three different serranid species in the southeastern United States and followed a trajectory that increased and then decreased over time. From these simulated populations, fishery-dependent length frequency data were generated and then altered to represent different types of systematic sampling error. Data that were biased towards larger fish had a considerable effect on t...
- Published
- 2009
27. Association Between Tumor Egfr and Kras Mutation Status and Clinical Outcomes in Nsclc Patients Randomized to Sorafenib Plus Best Supportive Care (BSC) or Bsc Alone: Subanalysis of the Phase III Mission Trial
- Author
-
Chris Twelves, J. Thompson, C. Fernández, H. Bonnefoi, Robert Jones, R. de Wit, Yves Humblet, C. Boni, T. Seto, P. Rougier, I.T. Rubio, S. McMahon, V. Patel, David Gentien, A. Santoro, José Baselga, M. Barrié, E. Ciruelos, R.A. Madan, U. Jungnelius, E. Esteban, H. Abbas, C. Robert, J. Martin, F. Selle, Dong Wook Kim, H. Singh-Jasuja, Arthur L. Klatsky, Harald A. Weber, A. Bonetti, Florence Lerebours, A. Hamed, Georgina V. Long, Véronique Diéras, A. Savarese, E.M. Guerra, Richard Bell, Nick Thatcher, M.S.L. Teng, Toni K. Choueiri, M. Untch, Nicole M. Kuderer, H-J. Lenz, D. Serin, A. Fandi, Frédéric Commo, Y-L. Wu, A.S. Daud, Kazuhiko Nakagawa, Debora Barton, D. Brewer, G. Folprecht, Frank Cihon, Michael Thomas, M. Fleischer, T. Nakajima, Mary Anne Armstrong, Jonathan Cebon, M. Rios, L. Gissmann, P. Preux, A. Loundou, Lluis M. Mir, F. Lordick, Lynn M. Schuchter, B. Vasseur, Ulrika Harmenberg, B. Massuti Sureda, M. Matta, X. Durando, C. Costa, J-P. Guastalla, Brigitte Sigal-Zafrani, S. Falk, Nicolas Servant, M. Campone, Richard M. Goldberg, Petronella O. Witteveen, A. Grothey, T. Olive, Andrea Wagner, L. Crinò, R. Rosell, T. De Pas, P. Attali, Mitchell Dowsett, M. Lacroix, Y. Xu, F. Hilpert, Benjamin Solomon, Enriqueta Felip, A. Pasic, D. Genet, A. Falcone, A. Niethammer, K. Tauer, D. Berton-Rigaud, L. Bedenne, Enrico Mini, J-P. Jacquin, J.-L. Van Laethem, Egbert F. Smit, R.J. Jones, David Cella, K. Pittman, W. Hwu, D. Bollag, Yan Li, Roma Parikh, P.J. Wiechno, C. Jouannaud, Masahiro Takeuchi, P. Slaouti, Eric Pujade-Lauraine, A. Sobrero, C. Campello, H. Y. Lim, Ellie Guardino, L.S. Schwartzberg, Margarita Majem, F. Dalenc, Bruno R. Bastos, P. Senico, J.S. de Bono, Olivier Rosmorduc, Bernard Asselain, J. Atkins, C. Centeno, F. Subtil, H.J.M. Groen, F. Bonnetain, Benjamin Besse, Sarah Pearson, N. Vogelzang, J.T. Hartmann, Susan J Dutton, B. Zaric, G.A. Bjarnason, S. Olsen, L. Jia, Jun Guo, L. Venat-Bouvet, R. D. Gelber, Silvia Novello, Etienne Brain, Carlo Barone, S. Lavau-Denes, S. Zhu, C.N. Sternberg, Roman Perez-Soler, V. Tassell, D. Frappaz, C. Cremolini, J. Clancy, D. Wan, G. Masi, M. Jensen, Richard F. Kefford, Michael Baum, D. Lu, A. Gonzalez Martin, Alain Algazi, C. Valsuani, A. Maubon, C. Heery, L. Cupit, R.J. Motzer, P. Kerbrat, N. Gadea, A. P. Dei Tos, C.S. Cooper, Ricardo J. Gonzalez, A. Vuorela, A. Gonçalves, H. Tan, Thomas E. Hutson, G. Goss, M. Frenay, M. Munill, R. Kudchakar, J. Schlom, L. Mineur, Max Bulsara, J. Wei, Y. Wang, T.J. Ong, Wasaburou Koizumi, Michael Staehler, F. Ghiringhelli, F. Barlesi, C. Mermel, M. Provansal, David R. Spigel, Bernard Escudier, C. Granetto, Trever G. Bivona, Gerold Meinhardt, Jaime R. Merchan, A. Chatterjee, L. Salvatore, Suzette Delaloge, D. Laurent, J. Clark, Fabrice Andre, I. Ray-Coquard, P. Salman, Peng Sun, S. Hodge, M. Schneider, Petr Kavan, B. Biesma, Paul Ross, A. Gimenez-Capitan, T. Schmelter, J. Ritchie, Jean-Yves Pierga, W. Mansoor, R. Hubner, C. Girault, S. Di Cosimo, D.W. Fyfe, G. Allegrini, Yang Sun, S. Burgers, J. Reeves, P. Mulholland, B. Chauffert, S.M. Steinberg, David R. Ferry, H.C. Chung, N. Budnik, Sang Cheul Oh, R. Gervais, M.A. Molina, Iben Spanggaard, X. Pivot, Anna C. Pavlick, Jeffrey Crawford, M. Schirripa, K. Fife, M. Davoudianfar, Alexander Reuss, C. Sonaglio, Elena Castro, Nicholas Choong, A. Kramar, I. Chan, J. Ferrero, M. Snoj, L. Peachey, Jaap Verweij, I. El-Hariry, H.A. Azim, E. Tabouret, P. Arlen, Ian Judson, M. Praet, J.C-H. Yang, D.G. Power, R. Schott, N. Karachaliou, R. Midgely, Lei Zhang, L. Paz-Ares, W.T.A. van der Graaf, J. Labourey, Andrew X. Zhu, H. Wang, A.D. Vincent, Chris Parker, Masashi Fujii, Hirotsugu Uemura, M-J. Ahn, J. Mehta, Lauren McCann, Samar Alsafadi, A.M. Poveda, Y. Lou, S. Peoples, K. Sivarajan, S. Chiara, P. Fumoleau, O. Aren, G. McArthur, J. Zhu, Julie Gehl, P. Laurent-Puig, Martine Piccart, J. Evans, Laurence Collette, K. B. Kim, Jeffrey S Tobias, J. A. Sosman, Carol Peña, Frederik Wenz, A. Goldhirsch, F. Teofilovici, J. Thaler, Jose Leal, P. Giannikopoulos, Mark A. Socinski, Patrick Julier, L. Boni, L. Cany, C. Boucard, Ludovic Lacroix, A. Dahle-Smith, Y-K. Kang, Yi-Long Wu, Ian E. Krop, C. Heredia, O. Ishibashi, M. Santarpia, Aoife M. Ryan, B. Leyland-Jones, Paul Nathan, A-M.C. Dingemans, F.H. Blackhall, Anna Polli, C. Lepage, L. Antonuzzo, S. Cushen, D-Y. Oh, C. Dalban, A. Mori, M. Espié, V. Semiglazov, MA LeBerre, J. Adelaide, Natalia Udaltsova, Nuhad K. Ibrahim, Richard Sullivan, D.A. Fennell, J. Skrzypski, G. Romieu, H. Eidtmann, J. Bosch-Barrera, Taofeek K. Owonikoko, M. DeSilvio, C. Jackisch, Robert J. Motzer, G. Sersa, F. Boudouresque, Russell D. Petty, S. Jefferies, T. Moran Bueno, M.O. Palumbo, M. Ouafik, J. Balmana, D. Valcárcel, S. Cupini, G. Bodoky, S. Szyldergemajn, A. Fabi, M. Cardoso, R. Allerton, U. Kenny, O. Chinot, Daniel J. Sargent, U. De Giorgi, Mark D. Pegram, J. M. Del Campo, J. Surralles, H. Oltean, A. Garcia-Alonso, Kensaku Yoshida, E. Juhasz, Howard I. Scher, H. Goette, David Baer, L. Fornaro, D. Cameron, Nicholas D. James, Thomas F. Gajewski, P. Lacroix, M. Harrison, G.D. Friedman, A. Enke, C. Bouquet, I. Bradbury, S. Halford, M. Jimenez, A. Chang, J-Y Pierga, P. Pultar, T. Bachelot, Daniel C. Danila, L. Eckert, J. Douillard, L. Burns, F. De Marinis, David Miles, Q. Wang, A. Vergnenegre, D. Khayat, F.J. Carrilho, H. Codrington, K. Wang, D. Moro-Sibilot, N. Bosch, J.L. Quesada, M.D. Dibonaventura, E. de Azambuja, S. Abadie-Lacourtoisie, Christophe Massard, L. Fang, I. Pauporte, L. Feuvret, C. Manegold, Ramon Luengo-Fernandez, M. Banzi, J.S. Guillamo, B. Żurawski, Suresh S. Ramalingam, J.L. Gulley, M. Liu, M. Ychou, O. Al-Salihi, T. Hutson, S. Santillana, Alice T. Shaw, I.E. Smith, S. Culine, H. Tailla, Kiran Patel, Patrick Schöffski, Adil Daud, Luca Gianni, R. Camidge, A. Lortholary, M. Lu, L. Taillandier, A. James, M. Procter, Carmen Criscitiello, Mika Mustonen, R. Rampling, Jayant S. Vaidya, D. Agbor-Tarh, T. Gamble, Subramanian Hariharan, Andrea Cavalcanti, R. Malik, Ignace Vergote, Sandrine Marreaud, Heather A. Wakelee, Shonda M Little, Hans Gelderblom, M. Arnedos Ballester, J. Tabernero, J. Honnorat, S. Li, O. Bouché, Isabelle Gilloteau, A. Goren, J.G. Aerts, J. Blay, W. Eiermann, D. Joseph, Jie Jin, J.F. Emile, Gerhardt Attard, Markus Moehler, Yang Hyun Kim, S. Verma, Nicole Tubiana-Mathieu, J. Taieb, G. Giaccone, Shahneen Sandhu, Kenneth J. O'Byrne, E. Van Cutsem, T. Yoshino, Saskia Litière, Keith T. Flaherty, J. R. Infante, Chetan Lathia, V. Vukovic, E. Giommoni, Alison Reid, S. Siena, Keith C. Deen, Tony Mok, J. Wang, J.S. Weber, Corey J. Langer, E. Fea, P. de Souza, C. Levy, K. Kumari, A. Casado, M. Welslau, Karl D. Lewis, O. Dalesio, R. Swaby, M. Fabbro, Brian I. Rini, Janusz Jankowski, Daniel P. Petrylak, Robert E. Hawkins, M. Mohebtash, A. Adenis, A. Ribas, Igor Puzanov, I. Tennevet, H. Kim, Karim Fizazi, O. Hamid, D. Olmos Hidalgo, J.A. Bridgewater, S. Catala, H. Melezinkova, G. Kurteva, Aristotle Bamias, F. Loupakis, Vera Hirsh, Pasi A. Jänne, Kimberly L. Blackwell, M.R. Garcia-Campelo, C. Kahatt, J. Bellmunt, and J. Alexandre
- Subjects
Oncology ,Sorafenib ,medicine.medical_specialty ,Proportional hazards model ,business.industry ,Hematology ,medicine.disease_cause ,Placebo ,medicine.disease ,Breast cancer ,Egfr mutation ,Internal medicine ,Medicine ,Biomarker (medicine) ,KRAS ,Stage (cooking) ,business ,medicine.drug - Abstract
Background Tumor EGFR and KRas mutations are both predictive and prognostic biomarkers in patients with advanced NSCLC. We analyzed the correlation between these biomarkers and treatment outcomes in a phase III trial of 3rd/4th line sorafenib in patients with NSCLC. Methods The global, randomized, placebo-controlled MISSION trial enrolled 703 patients with advanced relapsed/refractory NSCLC of predominantly non-squamous histology. The primary study endpoint was overall survival (OS). EGFR and KRas mutations were analyzed in archival tumor samples and in circulating tumor DNA isolated from plasma. Results Tumor and/or plasma mutation data were available from 347 patients (49%). EGFR and KRas mutations were detected in 89 (26%) and 68 (20%) patients, respectively, and were well balanced between treatment arms. Analysis of the interaction between EGFR mutation status and treatment effect on survival suggested that patients with EGFR mutations (mEGFR) benefitted from sorafenib, while those with wild-type EGFR (wtEGFR) did not (p = 0.023). Median OS was two-fold longer in mEGFR patients receiving sorafenib versus placebo (423 vs 197 days, HR 0.48, p = 0.002). There was no significant difference in OS between patients with wtEGFR receiving sorafenib or placebo (253 vs 256 days, HR 0.92, p = 0.559). An interaction was also seen between EGFR mutation status and the sorafenib effect on PFS (p = 0.015). Patients with mEGFR treated with sorafenib had better outcomes compared to placebo based on Cox regression analysis (HR 0.27, p Conclusion Post-hoc analyses of efficacy outcomes in MISSION suggest that advanced NSCLC patients with EGFR mutations may derive a survival benefit from receiving 3rd/4th line sorafenib. These results must be interpreted with caution due to the small, non-representative nature of the genetic biomarker subpopulation analyzed in this trial. Further prospective investigation may be warranted. Disclosure T.S.K. Mok: Honoraria: AstraZeneca, Roche, Eli Lilly, Merck Serono, Eisai, BMS, BeiGene, AVEO, Pfizer, Taiho, Boehringer Ingelheim, and GSK Biologicals Speaker: Astrazeneca, Roche, Eli Lilly, Boehringer Ingelheim, and Merck Serono Research funding: Astrazeneca. L. Paz-Ares: Dr. Paz-Ares has received honoraria from Bayer HealthCare Pharmaceuticals, Lilly, Roche and Pfizer. Y. Wu: Dr. Wu has received lecture fees from Roche, AstraZeneca, Eli Lilly, and Pfizer. V. Hirsh: Member of the steering committee for the MISSION trial. C. Lathia: Dr. Lathia is an employee of Bayer HealthCare. T.J. Ong: Dr. Ong is an employee of, and owns shares in, Bayer HealthCare. C. Pena: Dr. Pena is an employee of Bayer HealthCare. All other authors have declared no conflicts of interest.
- Published
- 2012
28. Bibron's Antidote
- Author
-
D O C, Heery
- Published
- 1859
29. A phase 2 study of a brachyury-targeting vaccine in combination with radiation therapy for the treatment of advanced chordoma.
- Author
-
Cote GM, Conley AP, Attia S, Van Tine BA, Seetharam M, Chen YL, Gafoor Z, Heery C, Pico-Navarro C, and Adams T
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Adult, Combined Modality Therapy, Fowlpox virus, Progression-Free Survival, Vaccinia virus immunology, Chordoma radiotherapy, Chordoma pathology, Fetal Proteins, T-Box Domain Proteins, Cancer Vaccines therapeutic use, Cancer Vaccines administration & dosage
- Abstract
Background: This was a single-arm, phase 2 clinical trial of Bavarian Nordic (BN)-Brachyury vaccine plus radiotherapy (RT) designed to determine the objective response rate (ORR), progression-free survival (PFS), and safety of the combination in chordoma., Methods: A total of 29 adult patients with advanced chordoma were treated with two subcutaneous priming vaccine doses of modified vaccinia Ankara-Bavarian Nordic (MVA-BN)-Brachyury and one vaccine dose of fowlpox virus (FPV)-Brachyury before RT. After RT, booster vaccinations were given with FPV-Brachyury every 4 weeks for 4 doses, then every 12 weeks (week 110). A minimum RT dose of >8 Gy in one fraction for each target was required. Response was evaluated by modified Response Evaluation Criteria in Solid Tumors 1.1 (mRECIST), where only radiated lesions were considered targets, and by standard RECIST 1.1 in a subset of patients., Results: Two of 26 evaluable patients experienced durable partial response (PR) (ORR of 7.7%; 90% confidence interval [CI], 2.6-20.8]) by mRECIST 1.1. A total of 21 patients (80.8%; 90% CI, 65.4-90.3) had stable disease, and three patients (11.5%; 90% CI, 4.7-25.6) had progressive disease as best response per mRECIST 1.1. Median PFS was not reached during the study., Conclusions: This trial confirms the safety of BN-Brachyury and RT. Although the study did not meet the predefined study goal of four responses in 29 patients, we did observe two PRs and a PFS of greater than 2 years. For a vaccine-based study in chordoma, an ultra-rare disease where response rates are low, a randomized study or novel trial designs may be required to confirm activity., (© 2024 American Cancer Society.)
- Published
- 2024
- Full Text
- View/download PDF
30. Avelumab in Patients With Metastatic Colorectal Cancer.
- Author
-
Redman JM, O'Sullivan Coyne G, Reed CT, Madan RA, Strauss J, Steinberg SJ, Marté J, Cordes L, Heery C, and Gulley JL
- Subjects
- Humans, Antibodies, Monoclonal adverse effects, Colonic Neoplasms, Rectal Neoplasms, Response Evaluation Criteria in Solid Tumors, Antibodies, Monoclonal, Humanized therapeutic use, Colorectal Neoplasms drug therapy
- Abstract
Background: Metastatic colorectal cancer (mCRC) is incurable, and median overall survival is less than 2½ years. Although monoclonal antibodies that block PD-1/PD-L1 interactions are active in microsatellite unstable/mismatch repair deficient tumors, a growing dataset shows that most patients with microsatellite stable/mismatch repair proficient tumors will not benefit from the blockade of PD-1/PD-L1 interactions. Here we present results from patients with mCRC (n = 22) treated with the anti-PD-L1 monoclonal antibody avelumab., Methods: Patients received treatment on a phase I, open-label, dose-escalation trial via a consecutive parallel-group expansion in colorectal cancer. Patients aged 18 years and older with mCRC measurable by RECIST v1.1 who had received at least 1 line of systemic therapy for metastatic disease enrolled. Patients with prior immune checkpoint inhibitor treatment were excluded. Patients received avelumab 10 mg/kg intravenously every 2 weeks. The primary endpoint was the objective response rate., Results: Twenty-two participants received treatment from July 2013 to August 2014. There were no objective responses and median progression-free survival was 2.1 months (95% CI: 1.4-5.5 months). There were 5 grade 3 treatment-related adverse events: GGT elevation (n = 2), PRESS (n = 1), lymphopenia (n = 1), and asymptomatic amylase/lipase elevation (n = 1)., Conclusion: As demonstrated with other anti-PD-1/PD-L1 monoclonal antibodies, avelumab is not active in unselected patients with mCRC (ClinicalTrials.gov Identifier: NCT01772004)., (Published by Oxford University Press 2023.)
- Published
- 2023
- Full Text
- View/download PDF
31. The NIH pediatric/young adult chordoma clinic and natural history study: Making advances in a very rare tumor.
- Author
-
John L, Smith H, Ilanchezhian M, Lockridge R, Reilly KM, Raygada M, Dombi E, Sandler A, Thomas BJ, Glod J, Miettinen M, Allen T, Sommer J, Levy J, Lozinsky S, Dix D, Bouffet E, MacDonald S, Mukherjee D, Snyderman CH, Rowan NR, Malyapa R, Park DM, Heery C, Gardner PA, Cote GM, Fuller S, Butman JA, Jackson S, Gulley JL, Widemann BC, and Wedekind MF
- Abstract
Background: Chordomas are rare tumors arising from the skull base and spine, with approximately 20 pediatric chordoma cases in the Unitedn States per year. The natural history and optimal treatment of pediatric chordomas, especially poorly differentiated and dedifferentiated subtypes, is incompletely understood. Herein, we present findings from our first National Cancer Institute (NCI) chordoma clinic and a retrospective analysis of published cases of pediatric poorly differentiated chordomas (PDC) and dedifferentiated chordomas (DC)., Methods: Patients less than 40 years old with chordoma were enrolled on the NCI Natural History and Biospecimens Acquisitions Study for Children and Adults with Rare Solid Tumors protocol (NCT03739827). Chordoma experts reviewed patient records, evaluated patients, and provided treatment recommendations. Patient-reported outcomes, biospecimens, and volumetric tumor analyses were collected. A literature review for pediatric PDC and DC was conducted., Results: Twelve patients (median age: 14 years) attended the clinic, including four patients with active disease and three patients with PDC responsive to systemic therapy. Consensus treatment, management, and recommendations were provided to patients. Literature review returned 45 pediatric cases of PDC or DC with variable treatments and outcomes., Conclusions: A multidisciplinary expert clinic was feasible and successful in improving understanding of pediatric chordoma. While multimodal approaches have all been employed, treatment for PDC has been inconsistent and a recommended standardized treatment approach has not been defined. Centralized efforts, inclusive of specialized chordoma-focused clinics, natural history studies, and prospective analyses will help in the standardization of care for this challenging disease., (© 2023 The Authors. Pediatric Blood & Cancer published by Wiley Periodicals LLC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.)
- Published
- 2023
- Full Text
- View/download PDF
32. Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma.
- Author
-
Frigault MJ, Bishop MR, Rosenblatt J, O'Donnell EK, Raje N, Cook D, Yee AJ, Logan E, Avigan DE, Jakubowiak A, Shaw K, Daley H, Nikiforow S, Griffin F, Cornwell C, Shen A, Heery C, and Maus MV
- Subjects
- Humans, Lymphocytes, Multiple Myeloma drug therapy, Neurotoxicity Syndromes, Receptors, Chimeric Antigen therapeutic use
- Abstract
Relapsed and refractory multiple myeloma (RRMM) is a plasma cell neoplasm defined by progressively refractory disease necessitating chronic and increasingly intensive therapy. Despite recent advances, limited treatment options exist for RRMM. This single-arm, open label phase 1 study aimed to evaluate the safety of novel B-cell maturation antigen (BCMA)-targeting chimeric antigen receptor (CAR) T construct that leverages a completely synthetic antigen-binding domain (CART-ddBCMA), which was specifically engineered to reduce immunogenicity and improve CAR cell surface stability. Thirteen patients ≥18 years with RRMM who received at least 3 prior regimens of systemic therapy were enrolled in the study. Patients received a single dose of 100 × 106 CART-ddBCMA (DL1) or 300 × 106 CART-ddBCMA (DL2) following standard lymphodepleting chemotherapy. The primary endpoints of the study were to evaluate the incidence of treatment emergent adverse events, including dose-limiting toxicities, and establish a recommended phase 2 dose. Results showed that CART-ddBCMA was well tolerated and demonstrated a favorable toxicity profile. Only 1 case of grade ≥3 cytokine release syndrome and 1 case of immune effector cell-associated neurotoxicity were reported; both were at DL2 and were manageable with standard treatment. No atypical neurological toxicities and Parkinson disease-like movement disorders were observed. The maximum tolerated dose was not reached. All infused patients responded to CART-ddBCMA, and 9/12 (75%) patients achieved complete response/stringent complete response. Responses deepened over time, and at the time of last data-cut (median follow-up 56 weeks), 8/9 (89%) evaluable patients achieved minimal residual disease negativity. In conclusion, the findings demonstrate the safety of CART-ddBCMA cells and document durable responses to CART-ddBCMA in patients with RRMM. This trial was registered at www.clinicaltrials.gov as #NCT04155749., (© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
33. Dose fractionation of CAR-T cells. A systematic review of clinical outcomes.
- Author
-
Frigault M, Rotte A, Ansari A, Gliner B, Heery C, and Shah B
- Subjects
- Child, Humans, Immunotherapy, Adoptive adverse effects, Cytokine Release Syndrome, T-Lymphocytes pathology, Hematologic Neoplasms pathology, Neurotoxicity Syndromes therapy
- Abstract
CAR-T cells are widely recognized for their potential to successfully treat hematologic cancers and provide durable response. However, severe adverse events such as cytokine release syndrome (CRS) and neurotoxicity are concerning. Our goal is to assess CAR-T cell clinical trial publications to address the question of whether administration of CAR-T cells as dose fractions reduces toxicity without adversely affecting efficacy. Systematic literature review of studies published between January 2010 and May 2022 was performed on PubMed and Embase to search clinical studies that evaluated CAR-T cells for hematologic cancers. Studies published in English were considered. Studies in children (age < 18), solid tumors, bispecific CAR-T cells, and CAR-T cell cocktails were excluded. Data was extracted from the studies that met inclusion and exclusion criteria. Review identified a total of 18 studies that used dose fractionation. Six studies used 2-day dosing schemes and 12 studies used 3-day schemes to administer CAR-T cells. Three studies had both single dose and fractionated dose cohorts. Lower incidence of Grade ≥ 3 CRS and neurotoxicity was seen in fractionated dose cohorts in 2 studies, whereas 1 study reported no difference between single and fractionated dose cohorts. Dose fractionation was mainly recommended for high tumor burden patients. Efficacy of CAR-T cells in fractionated dose was comparable to single dose regimen within the same or historical trial of the same agent in all the studies. The findings suggest that administering dose fractions of CAR-T cells over 2-3 days instead of single dose infusion may mitigate the toxicity of CAR-T cell therapy including CRS and neurotoxicity, especially in patients with high tumor burden. However, controlled studies are likely needed to confirm the benefits of dose fractionation., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
34. Dose-response correlation for CAR-T cells: a systematic review of clinical studies.
- Author
-
Rotte A, Frigault MJ, Ansari A, Gliner B, Heery C, and Shah B
- Subjects
- Child, Humans, Adolescent, T-Lymphocytes, Immunotherapy, Adoptive adverse effects, Treatment Outcome, Neoplasms therapy, Neoplasms etiology, Hematologic Neoplasms therapy
- Abstract
The potential of chimeric antigen receptor (CAR) T cells to successfully treat hematological cancers is widely recognized. Multiple CAR-T cell therapies are currently under clinical development, with most in early stage, during which dose selection is a key goal. The objective of this review is to address the question of dose-dependent effects on response and/or toxicity from available CAR-T cell clinical trial data. For that purpose, systematic literature review of studies published between January 2010 and May 2022 was performed on PubMed and Embase to search clinical studies that evaluated CAR-T cells for hematological cancers. Studies published in English were considered. Studies in children (age <18 years), solid tumors, bispecific CAR-T cells and CAR-T cell cocktails were excluded. As a result, a total of 74 studies met the inclusion criteria. Thirty-nine studies tested multiple dose levels of CAR-T cells with at least >1 patient at each dose level. Thirteen studies observed dose-related increase in disease response and 23 studies observed dose-related increase in toxicity across a median of three dose levels. Optimal clinical efficacy was seen at doses 50-100 million cells for anti-CD19 CAR-T cells and >100 million cells for anti-BCMA CAR-T cells in majority of studies. The findings suggest, for a given construct, there exists a dose at which a threshold of optimal efficacy occurs. Dose escalation may reveal increasing objective response rates (ORRs) until that threshold is reached. However, when ORR starts to plateau despite increasing dose, further dose escalation is unlikely to result in improved ORR but is likely to result in higher incidence and/or severity of mechanistically related adverse events., Competing Interests: Competing interests: AR, CH and BG are employees of Arcellx and hold stocks in the company. AA is a consultant to Arcellx. BS reports honoraria from Pharmacyclics, Janssen, Acrotech, Spectrum, BeiGene and Gilead Sciences; a consultancy or advisory role for Adaptive Biotechnologies, Bristol Myers Squibb/Celgene, Novartis, Pfizer, Amgen, Precision Biosciences and Kite, a Gilead Company; research funding from Incyte, Jazz Pharmaceuticals, Gilead Sciences and Kite; and travel support from Celgene, Novartis, Pfizer, Janssen, Seattle Genetics, Stemline Therapeutics and Kite. MJF reports a consultancy role for Celgene, Novartis, Arcellx and Gilead/Kite; research funding from Novartis and Gilead/Kite., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
35. Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer.
- Author
-
DeMaria PJ, Lee-Wisdom K, Donahue RN, Madan RA, Karzai F, Schwab A, Palena C, Jochems C, Floudas C, Strauss J, Marté JL, Redman JM, Dombi E, Widemann B, Korchin B, Adams T, Pico-Navarro C, Heery C, Schlom J, Gulley JL, and Bilusic M
- Subjects
- Cancer Vaccines pharmacology, Female, Fetal Proteins pharmacology, Humans, Male, Middle Aged, T-Box Domain Proteins pharmacology, Vaccines, Synthetic pharmacology, Vaccines, Synthetic therapeutic use, Administration, Intravenous methods, Cancer Vaccines therapeutic use, Fetal Proteins therapeutic use, Immunotherapy methods, Neoplasms drug therapy, T-Box Domain Proteins therapeutic use
- Abstract
Background: MVA-BN-brachyury-TRICOM is a recombinant vector-based therapeutic cancer vaccine designed to induce an immune response against brachyury. Brachyury, a transcription factor overexpressed in advanced cancers, has been associated with treatment resistance, epithelial-to-mesenchymal transition, and metastatic potential. MVA-BN-brachyury-TRICOM has demonstrated immunogenicity and safety in previous clinical trials of subcutaneously administered vaccine. Preclinical studies have suggested that intravenous administration of therapeutic vaccines can induce superior CD8
+ T cell responses, higher levels of systemic cytokine release, and stronger natural killer cell activation and proliferation. This is the first-in-human study of the intravenous administration of MVA-BN-brachyury-TRICOM., Methods: Between January 2020 and March 2021, 13 patients were treated on a phase 1, open-label, 3+3 design, dose-escalation study at the National Institutes of Health Clinical Center. The study population was adults with advanced solid tumors and was enriched for chordoma, a rare sarcoma of the notochord that overexpresses brachyury. Vaccine was administered intravenously at three DLs on days 1, 22, and 43. Blood samples were taken to assess drug pharmacokinetics and immune activation. Imaging was conducted at baseline, 1 month, and 3 months post-treatment. The primary endpoint was safety and tolerability as determined by the frequency of dose-limiting toxicities; a secondary endpoint was determination of the recommended phase 2 dose., Results: No dose-limiting toxicities were observed and no serious adverse events were attributed to the vaccine. Vaccine-related toxicities were consistent with class profile (ie, influenza-like symptoms). Cytokine release syndrome up to grade 2 was observed with no adverse outcomes. Dose-effect trend was observed for fever, chills/rigor, and hypotension. Efficacy analysis of objective response rate per RECIST 1.1 at the end of study showed one patient with a partial response, four with stable disease, and eight with progressive disease. Three patients with stable disease experienced clinical benefit in the form of improvement in pain. Immune correlatives showed T cell activation against brachyury and other tumor-associated cascade antigens., Conclusions: Intravenous administration of MVA-BN-brachyury-TRICOM vaccine was safe and tolerable. Maximum tolerated dose was not reached. The maximum administered dose was 109 infectious units every 3 weeks for three doses. This dose was selected as the recommended phase 2 dose., Trial Registration Number: NCT04134312., Competing Interests: Competing interests: BK: Bavarian Nordic (E). TA: Bavarian Nordic (E). CP-N: Bavarian Nordic (E). CH: Arcellx (E) (previously employed by Bavarian Nordic). The other authors indicate no financial relationships. (E) Employment., (© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)- Published
- 2021
- Full Text
- View/download PDF
36. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group.
- Author
-
Stacchiotti S, Gronchi A, Fossati P, Akiyama T, Alapetite C, Baumann M, Blay JY, Bolle S, Boriani S, Bruzzi P, Capanna R, Caraceni A, Casadei R, Colia V, Debus J, Delaney T, Desai A, Dileo P, Dijkstra S, Doglietto F, Flanagan A, Froelich S, Gardner PA, Gelderblom H, Gokaslan ZL, Haas R, Heery C, Hindi N, Hohenberger P, Hornicek F, Imai R, Jeys L, Jones RL, Kasper B, Kawai A, Krengli M, Leithner A, Logowska I, Martin Broto J, Mazzatenta D, Morosi C, Nicolai P, Norum OJ, Patel S, Penel N, Picci P, Pilotti S, Radaelli S, Ricchini F, Rutkowski P, Scheipl S, Sen C, Tamborini E, Thornton KA, Timmermann B, Torri V, Tunn PU, Uhl M, Yamada Y, Weber DC, Vanel D, Varga PP, Vleggeert-Lankamp CLA, Casali PG, and Sommer J
- Subjects
- Humans, Neoplasm Recurrence, Local, Chordoma therapy, Practice Guidelines as Topic
- Abstract
Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and suboptimal outcomes for many patients. To address this shortcoming, the European Society of Medical Oncology (ESMO) and the Chordoma Foundation, the global chordoma patient advocacy group, convened a multi-disciplinary group of chordoma specialists to define by consensus evidence-based best practices for the optimal approach to chordoma. In January 2015, the first recommendations of this group were published, covering the management of primary and metastatic chordomas. Additional evidence and further discussion were needed to develop recommendations about the management of local-regional failures. Thus, ESMO and CF convened a second consensus group meeting in November 2015 to address the treatment of locally relapsed chordoma. This meeting involved over 60 specialists from Europe, the United States and Japan with expertise in treatment of patients with chordoma. The consensus achieved during that meeting is the subject of the present publication and complements the recommendations of the first position paper., (© The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology.)
- Published
- 2017
- Full Text
- View/download PDF
37. Nuclear Brachyury Expression Is Consistent in Chordoma, Common in Germ Cell Tumors and Small Cell Carcinomas, and Rare in Other Carcinomas and Sarcomas: An Immunohistochemical Study of 5229 Cases.
- Author
-
Miettinen M, Wang Z, Lasota J, Heery C, Schlom J, and Palena C
- Subjects
- Carcinoma, Small Cell pathology, Cell Nucleus metabolism, Chordoma pathology, Female, Humans, Male, Neoplasms, Germ Cell and Embryonal pathology, Predictive Value of Tests, Prognosis, Sarcoma pathology, Biomarkers, Tumor analysis, Carcinoma, Small Cell chemistry, Cell Nucleus chemistry, Chordoma chemistry, Fetal Proteins analysis, Immunohistochemistry, Neoplasms, Germ Cell and Embryonal chemistry, Sarcoma chemistry, T-Box Domain Proteins analysis
- Abstract
Brachyury is a transcription factor of the T-box family typically expressed in notochord and chordoma. Some studies report brachyury as highly specific for chordoma, whereas others have concluded that brachyury is expressed in many types of common carcinomas by reverse transcription polymerase chain reaction and immunohistochemistry and could be involved in the epithelial-mesenchymal transition and metastatic process. In this study, we immunohistochemically evaluated 5229 different tumors for nuclear brachyury expression using a new rabbit monoclonal antibody and automated immunostaining (Leica Bond Max). Only nuclear labeling was scored, and antibody dilution of 1:2000 was used. In normal tissues, only rare cells in seminiferous tubules were labeled; all other organs were negative. All chordomas (75/76), except a sarcomatous one, were positive, whereas chondrosarcomas were negative. Among epithelial tumors, positivity was often detected in embryonal carcinoma (74%) and seminoma (45%). Pulmonary small cell carcinoma was often positive (41%), whereas pulmonary and pancreatic adenocarcinomas only rarely showed nuclear brachyury positivity (3% to 4%). Common carcinomas such as ductal carcinomas of the breast or adenocarcinomas of the prostate only exceptionally showed nuclear positivity (<1%). No colorectal, hepatocellular, renal cell, squamous cell, thyroid or urothelial carcinoma, or mesothelioma showed nuclear brachyury positivity. Among mesenchymal and neuroectodermal tumors, only isolated cases of melanoma, malignant peripheral nerve sheath tumor, rhabdomyosarcoma, synovial sarcoma, and follicular lymphoma showed nuclear expression. However, as shown previously with lung carcinoma, experiments with lower antibody dilutions (1:200 to 1:500) showed weak cytoplasmic and nuclear labeling in breast cancers. In addition to chordoma, we show here for the first time that nuclear brachyury expression is prevalent in embryonal carcinoma, seminoma, and small cell carcinoma of the lung but very rare in common carcinomas, sarcomas, and melanoma. With these reservations, we have demonstrated the presence of nuclear brachyury immunoreactivity to be a sensitive and fairly specific marker for chordoma.
- Published
- 2015
- Full Text
- View/download PDF
38. Detection and Characterization of Circulating Tumour Cells from Frozen Peripheral Blood Mononuclear Cells.
- Author
-
Lu D, Graf RP, Harvey M, Madan RA, Heery C, Marte J, Beasley S, Tsang KY, Krupa R, Louw J, Wahl J, Bales N, Landers M, Marrinucci D, Schlom J, Gulley JL, and Dittamore R
- Abstract
Retrospective analysis of patient tumour samples is a cornerstone of clinical research. CTC biomarker characterization offers a non-invasive method to analyse patient samples. However, current CTC technologies require prospective blood collection, thereby reducing the ability to utilize archived clinical cohorts with long-term outcome data. We sought to investigate CTC recovery from frozen, archived patient PBMC pellets. Matched samples from both mCRPC patients and mock samples, which were prepared by spiking healthy donor blood with cultured prostate cancer cell line cells, were processed "fresh" via Epic CTC Platform or from "frozen" PBMC pellets. Samples were analysed for CTC enumeration and biomarker characterization via immunofluorescent (IF) biomarkers, fluorescence in-situ hybridization (FISH) and CTC morphology. In the frozen patient PMBC samples, the median CTC recovery was 18%, compared to the freshly processed blood. However, abundance and localization of cytokeratin (CK) and androgen receptor (AR) protein, as measured by IF, were largely concordant between the fresh and frozen CTCs. Furthermore, a FISH analysis of PTEN loss showed high concordance in fresh vs. frozen. The observed data indicate that CTC biomarker characterization from frozen archival samples is feasible and representative of prospectively collected samples.
- Published
- 2015
- Full Text
- View/download PDF
39. Clinical evaluation of TRICOM vector therapeutic cancer vaccines.
- Author
-
Madan RA, Bilusic M, Heery C, Schlom J, and Gulley JL
- Subjects
- Animals, Antigens, Neoplasm immunology, Cancer Vaccines genetics, Clinical Trials as Topic, Humans, Male, Prostatic Neoplasms immunology, Transgenes, Vaccines, Synthetic immunology, Vaccines, Synthetic pharmacology, Cancer Vaccines immunology, Cancer Vaccines pharmacology, Immunotherapy methods, Prostatic Neoplasms drug therapy
- Abstract
We have developed an "off-the-shelf" vector-based vaccine platform containing transgenes for carcinoma-associated antigens and multiple costimulatory molecules (designated TRICOM). Two TRICOM platforms have been evaluated both preclinically and in clinical trials. PROSTVAC consists of rV, rF-PSA-TRICOM and is being used in prostate cancer therapy trials. PANVAC consists of rV, rF-CEA-MUC1-TRICOM; the expression of the two pan-carcinoma transgenes CEA and MUC-1 renders PANVAC vaccination applicable for therapeutic applications for a range of human carcinomas. Many new paradigms have emerged as a consequence of completed and ongoing TRICOM vaccine trials, including (1) clinical evidence of patient benefit may be delayed, because multiple vaccinations may be necessary to induce a sufficient anti-tumor immune response; (2) survival, and not strict adherence to RECIST criteria or time-to-progression, may be the most appropriate trial endpoint when TRICOM vaccines are used as monotherapy; (3) certain patient populations are more likely to benefit from vaccine therapy as compared to other therapeutics; and (4) TRICOM vaccines combined with standard-of-care therapeutics, either concomitantly or sequentially, are feasible because of the limited toxicity of vaccines., (Published by Elsevier Inc.)
- Published
- 2012
- Full Text
- View/download PDF
40. Immunotherapy in prostate cancer: emerging strategies against a formidable foe.
- Author
-
Bilusic M, Heery C, and Madan RA
- Subjects
- Clinical Trials as Topic, Drug Therapy, Combination methods, Humans, Male, Treatment Outcome, Cancer Vaccines therapeutic use, Immunotherapy methods, Prostatic Neoplasms therapy
- Abstract
Recent clinical trials have shown therapeutic vaccines to be promising treatment modalities against prostate cancer. Unlike preventive vaccines that teach the immune system to fight off specific microorganisms, therapeutic vaccines stimulate the immune system to recognize and attack certain cancer-associated proteins. Additional strategies are being investigated that combine vaccines and standard therapeutics, including radiation, chemotherapy, targeted therapies, and hormonal therapy, to optimize the vaccines' effects. Recent vaccine late-phase clinical trials have reported evidence of clinical benefit while maintaining excellent quality of life. One such vaccine, sipuleucel-T, was recently FDA-approved for the treatment of metastatic prostate cancer. Another vaccine, PSA-TRICOM, is also showing promise in completed and ongoing randomized multicenter clinical trials in both early- and late-stage prostate cancer. Clinical results available to date indicate that immune-based therapies could play a significant role in the treatment of prostate and other malignancies., (Published by Elsevier Ltd.)
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.